A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Caduceus LAUNCH Selects Six Digital Health Startups for Fall AcceleratorHealthradar12. September 2025 What You Should Know: – Caduceus LAUNCH, a digital health accelerator program, has announced the selection of six new startups…
Health Caduceus Capital Partners Forms Digital Health Consulting Arm Caduceus ADVISORYHealthradar18. Juli 2025 Adam Bauer Named CEO of New Business NASHVILLE, Tenn.–(BUSINESS WIRE)–#digitalhealth—Caduceus Capital Partners (Caduceus) today announced the formation of Caduceus ADVISORY,…
